Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Aroclor 1254: Target Organs and Levels of Evidence for TR-038

Bioassay of Aroclor® for Possible Carcinogenicity (CASRN 27323-18-8)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Aroclor 1254 11097-69-1	11/28/1977	Dosed-Feed 0,25,50,100 PPM/24 PER GROUP	SRI International

Levels of Evidence

Male Rats: Equivocal

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Liver: (CARCINOMA) Intestines: (ADENOCARCINOMA)

Female Rats: Equivocal

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Liver: (ADENOMA) Intestines: (ADENOCARCINOMA)